Proposed Data Collections Submitted for Public Comment and Recommendations, 51269-51270 [2010-20569]
Download as PDF
<![CDATA[
51269
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
FEDERAL RESERVE SYSTEM
Government in the Sunshine Meeting
Notice
Board of
Governors of the Federal Reserve
System.
TIME AND DATE: 11:30 a.m., Monday,
August 23, 2010.
PLACE: Marriner S. Eccles Federal
Reserve Board Building, 20th and C
Streets, NW., Washington, DC 20551.
STATUS: Closed.
MATTERS TO BE CONSIDERED: 1.
Implications of Dodd-Frank Reform Act
for Board Organization and Staffing.
(This item was originally announced on
July 27, 2010, for a closed meeting on
August 3, 2010.)
FOR MORE INFORMATION PLEASE CONTACT:
Michelle Smith, Director, or Dave
Skidmore, Assistant to the Board, Office
of Board Members at 202–452–2955.
SUPPLEMENTARY INFORMATION: You may
call 202–452–3206 beginning at
approximately 5 p.m. two business days
before the meeting for a recorded
announcement of bank and bank
holding company applications
scheduled for the meeting; or you may
contact the Board’s Web site at https://
www.federalreserve.gov for an electronic
announcement that not only lists
applications, but also indicates
procedural and other information about
the meeting.
AGENCY HOLDING THE MEETING:
Proposed Project
The Gonococcal Isolate Surveillance
Project (GISP) (OMB No. 0920–0307
exp. 3/31/2011)—Extension—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Dated: August 16, 2010.
Robert deV. Frierson,
Deputy Secretary of the Board.
Background and Brief Description
The objectives of GISP are: (1) To
monitor trends in antimicrobial
susceptibility of strains of Neisseria
gonorrhoeae in the United States and (2)
to characterize resistant isolates. GISP
provides critical surveillance for
antimicrobial resistance, allowing for
informed treatment recommendations.
Monitoring antibiotic susceptibility is
critical since Neisseria gonorrhoeae has
demonstrated the consistent ability to
gain antibiotic resistance. GISP was
established in 1986 as a voluntary
surveillance project and now involves 5
regional laboratories and 30 publicly
funded sexually transmitted disease
(STD) clinics around the country. The
STD clinics submit up to 25 gonococcal
[FR Doc. 2010–20677 Filed 8–17–10; 11:15 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60–Day 10–0307]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
emcdonald on DSK2BSOYB1PROD with NOTICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
isolates per month to the regional
laboratories, which measure
susceptibility to a panel of antibiotics.
Limited demographic and clinical
information corresponding to the
isolates are submitted directly by the
clinics to CDC.
During 1986–2009, GISP has
demonstrated the ability to effectively
achieve its objectives. The emergence of
resistance in the United States to
penicillin, tetracyclines, and
fluoroquinolones among Neisseria
gonorrhoeae isolates was identified
through GISP. Increased prevalence of
fluoroquinolone-resistant N.
gonorrhoeae (QRNG), as documented by
GISP data, prompted CDC to update
treatment recommendations for
gonorrhea in CDC’s Sexually
Transmitted Diseases Treatment
Guidelines, 2006 and to release an
MMWR article stating that CDC no
longer recommended fluoroquinolones
for treatment of gonococcal infections.
Under the GISP protocol, each of the
30 clinics submit an average of 20
isolates per clinic per month (i.e., 240
times per year) recorded on Form 1. The
estimated time for clinical personnel to
abstract data for Form 1 is 11 minutes
per response.
Each of the 5 Regional laboratories
receives and processes an average of 20
isolates from 6 different clinics per
month (i.e., 120 isolates per regional
laboratory per month) using Form 2. For
Form 2, the annual frequency of
responses per respondent is 1,440 (120
isolates × 12 months). Based on
previous laboratory experience, the
estimated burden for each participating
laboratory for Form 2 is 1 hour per
response, which includes the time
required for laboratory processing of the
patient’s isolate, gathering and
maintaining the data needed, and
completing and reviewing the collection
of information. For Form 3, a ‘‘response’’
is defined as the processing and
recording of Regional laboratory data for
a set of 7 control strains. It takes
approximately 12 minutes to process
and record the Regional laboratory data
on Form 3 for one set of 7 control
strains, of which there are 4 sets. The
number of responses per respondent is
48 (4 sets × 12 months). There is no cost
to the respondents other than their time.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Form name
Clinic ...................................................................
Laboratory ..........................................................
Form 1 .............
Form 2 .............
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
PO 00000
Frm 00032
Number of
responses per
respondent
Number of
respondents
Type of respondent
Fmt 4703
30
5
Sfmt 4703
Average burden
per response
(in hours)
240
1,440
E:\FR\FM\19AUN1.SGM
11/60
1
19AUN1
Total annual
burden
(in hours)
1,320
7,200
51270
Federal Register / Vol. 75, No. 160 / Thursday, August 19, 2010 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Type of respondent
Number of
responses per
respondent
Number of
respondents
Form name
Average burden
per response
(in hours)
Total annual
burden
(in hours)
Form 3 .............
Total ............................................................
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2010–20569 Filed 8–18–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
5
48
12/60
48
.........................
40
............................
............................
8,568
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Centers for Disease Control and
Prevention
Behavioral Assessment Component of
the Behavioral Assessment and Rapid
Testing (BART) Project—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, (NCHHSTP),
Centers for Disease Control and
Prevention, (CDC).
[60Day–10–10GT]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
Background and Brief Description
This Behavioral Assessment and
Rapid Testing project will involve
conducting behavioral assessments and
rapid HIV testing at a variety of events
serving groups at high risk for acquiring
or transmitting HIV infection.
Behavioral assessments will be
conducted using one protocol and one
research agenda but at events serving
different minority and hard-to-reach
populations. This project will address
the increasing rates of HIV infection
among African Americans (AAs) and
men who have sex with men as well as
the need for early detection and linkage
to health care for HIV-infected persons.
The behavioral assessment component
will provide the opportunity to describe
the risk profiles and prevalence of
unrecognized infection among
individuals reachable for HIV
counseling and testing at these events.
Collected data will be used to develop
risk reduction interventions that are
appropriate for the attendees of future
events that attract persons who may be
at high risk for HIV infection. The
proposed project addresses ‘‘Healthy
People 2010’’ priority area(s) of
identifying new HIV infections and is in
alignment with NCHHSTP performance
goal(s) to strengthen the capacity
nationwide to monitor the HIV
epidemic, develop and implement
effective HIV prevention interventions,
and evaluate prevention programs.
The purpose of the proposed data
collection is to collect behavioral data at
selected public events serving specific
high-risk populations and to increase
the proportion of at-risk persons who
are aware of their HIV status. The
behavioral assessment component of the
project addresses the need for increased
behavioral data among some high-risk
groups that are more difficult to access
or represent increasingly greater
proportions of the HIV epidemic.
A convenience sample will be used to
select attendees at (1) Gay Pride; (2)
Minority Gay Pride; (3) black spring
break; and (4) cultural and social events
attracting large numbers of African
Americans. Trained interviewers will
select and approach event attendees. A
screener questionnaire will be used to
determine participation eligibility and
obtain oral consent. Approximately
7,000 individuals will be approached
and screened (through a 2-minute
interview) for eligibility to participate
each year. Approximately 5,600
individuals are expected to be eligible
and participate in the 5- to 15-minute
behavioral assessment interview each
year. There is no cost to respondents
other than their time.
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
responses per
espondent
Number of
respondents
Average burden
per response
(hours)
Total burden
(in hours)
emcdonald on DSK2BSOYB1PROD with NOTICES
Respondent
Form
—African American males and females
(18+ yrs) at cultural/social events.
—Males (18+ yrs) at gay pride events
—Racial/ethnic minority males (18+ yrs) at
minority gay pride events
—African American males and females
(18–35 yrs) at spring break festivals
—African American males and females
(18+ yrs) at cultural/social events.
Eligibility Screener ...
7,000
1
2/60
233
Behavioral Assessment.
5,600
1
15/60
1,400
VerDate Mar<15>2010
17:05 Aug 18, 2010
Jkt 220001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 75, Number 160 (Thursday, August 19, 2010)]
[Notices]
[Pages 51269-51270]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-20569]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day 10-0307]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960 or
send comments to Maryam Daneshvar, CDC Reports Clearance Officer, 1600
Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
The Gonococcal Isolate Surveillance Project (GISP) (OMB No. 0920-
0307 exp. 3/31/2011)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The objectives of GISP are: (1) To monitor trends in antimicrobial
susceptibility of strains of Neisseria gonorrhoeae in the United States
and (2) to characterize resistant isolates. GISP provides critical
surveillance for antimicrobial resistance, allowing for informed
treatment recommendations. Monitoring antibiotic susceptibility is
critical since Neisseria gonorrhoeae has demonstrated the consistent
ability to gain antibiotic resistance. GISP was established in 1986 as
a voluntary surveillance project and now involves 5 regional
laboratories and 30 publicly funded sexually transmitted disease (STD)
clinics around the country. The STD clinics submit up to 25 gonococcal
isolates per month to the regional laboratories, which measure
susceptibility to a panel of antibiotics. Limited demographic and
clinical information corresponding to the isolates are submitted
directly by the clinics to CDC.
During 1986-2009, GISP has demonstrated the ability to effectively
achieve its objectives. The emergence of resistance in the United
States to penicillin, tetracyclines, and fluoroquinolones among
Neisseria gonorrhoeae isolates was identified through GISP. Increased
prevalence of fluoroquinolone-resistant N. gonorrhoeae (QRNG), as
documented by GISP data, prompted CDC to update treatment
recommendations for gonorrhea in CDC's Sexually Transmitted Diseases
Treatment Guidelines, 2006 and to release an MMWR article stating that
CDC no longer recommended fluoroquinolones for treatment of gonococcal
infections.
Under the GISP protocol, each of the 30 clinics submit an average
of 20 isolates per clinic per month (i.e., 240 times per year) recorded
on Form 1. The estimated time for clinical personnel to abstract data
for Form 1 is 11 minutes per response.
Each of the 5 Regional laboratories receives and processes an
average of 20 isolates from 6 different clinics per month (i.e., 120
isolates per regional laboratory per month) using Form 2. For Form 2,
the annual frequency of responses per respondent is 1,440 (120 isolates
x 12 months). Based on previous laboratory experience, the estimated
burden for each participating laboratory for Form 2 is 1 hour per
response, which includes the time required for laboratory processing of
the patient's isolate, gathering and maintaining the data needed, and
completing and reviewing the collection of information. For Form 3, a
``response'' is defined as the processing and recording of Regional
laboratory data for a set of 7 control strains. It takes approximately
12 minutes to process and record the Regional laboratory data on Form 3
for one set of 7 control strains, of which there are 4 sets. The number
of responses per respondent is 48 (4 sets x 12 months). There is no
cost to the respondents other than their time.
Estimate of Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden Total annual
Type of respondent Form name Number of responses per per response (in burden (in
respondents respondent hours) hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Clinic........................................ Form 1.......................... 30 240 11/60 1,320
Laboratory.................................... Form 2.......................... 5 1,440 1 7,200
[[Page 51270]]
Form 3.......................... 5 48 12/60 48
-----------------------------------------------------------------------
Total..................................... ................................ 40 ................ ................ 8,568
--------------------------------------------------------------------------------------------------------------------------------------------------------
Maryam I. Daneshvar,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-20569 Filed 8-18-10; 8:45 am]
BILLING CODE 4163-18-P
